TCL Archive FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly. May 6, 2005
TCL Archive Response From Center Representatives In L.A. To NCI Questions Is “Frusterating,” DeVita Says April 13, 1984
TCL Archive DCT Board Committee Drawing Up Plans On How To Spend Biological Response Modifiers Money August 31, 1979
